Current Research

We believe in supporting and contributing to research on the benefits of working with iboga

Magnesium-Ibogaine therapy in veterans with traumatic brain injury.

Stanford Medicine researchers find that ibogaine, a plant-based psychoactive compound, safely led to improvements in depression, anxiety, and functioning among veterans with traumatic brain injuries.

First Iboga Micro-dosing Study

We are preparing to run the first iboga micro-dosing study. Our application has been submitted to the Institutional Review Board and is under review. This study plans to look at the impact of micro-dosing iboga on 1) lifestyle indicators like sleep, nutrition, and substance use, 2) psychological indicators like anxiety, depression, joy, and trust, 3) satisfaction measures like family, career, relationship, finances, creative expression, and physical, mental and spiritual health and 4) quality indicators like fitness, focus, sexual health, and creativity. Study participants will complete surveys prior to the six-week micro-dosing protocol, at the six-week completion, and at a three month follow up.

We are actively recruiting participants through 2024. Please connect with us if you would like to participate.